Article
Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G→A).
Journal of inherited metabolic disease - 1 Oct 2010
Lin Hsiang-Yu, Huang Cheng-Hung, Yu Hsiao-Chi, Chong Kah-Wai, Hsu Ju-Hui, Lee Pi-Chang, Cheng Kang-Hsiang, Chiang Chuan-Chi, Ho Huey-Jane, Lin Shuan-Pei, Chen Shih-Jen, Lin Po-Kang, Niu Dau-Ming
Abstract excerpt
Newborn screening for Fabry disease in Taiwan Chinese has revealed a high incidence of the late-onset GLA mutation IVS4 + 919G→A (∼1 in 1,500-1,600 males). We studied 94 adults with this mutation [22 men, 72 women; mean age: men 57.8 ± 6.0 (range 42-68), women 39.1 ± 14.1 years (range 19-82)]. Plasma α-galactosidase A activity assay was 10.4 ± 11.2% of normal in the men and 48.6 ± 19.5% of normal in the women....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
